📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The effect of GLP-1RA exenatide on Idiopathic Intracranial Hypertension: Randomised Clinical Trial (2022)

First Author: Mitchell J

Attributed to: MICA: Assessing the therapeutic efficacy of 11beta-hydroxysteroid dehydrogenase type 1 inhibitor (AZD4017) in idiopathic intracranial hypertension funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2022.05.24.22275518

Publication URI: http://dx.doi.org/10.1101/2022.05.24.22275518

Type: Preprint